Walker R M, Patel A, St Clair Carter S
Department of Urology, Charing Cross Hospital, London, UK.
Br J Urol. 1998 Feb;81(2):206-10. doi: 10.1046/j.1464-410x.1998.00531.x.
To determine the effect of urethral instrumentation on pressure-flow study values and subsequent grading of bladder outflow obstruction (BOO) in men with lower urinary tract symptoms (LUTS) using suprapubic intravesical pressure monitoring.
Seventy-two men with LUTS underwent pressure-flow study using suprapubic intravesical pressure monitoring. The urethra was then instrumented successively with a 12 F catheter and a 17 F cystoscope, and a further pressure-flow study recorded after each procedure. Standard pressure-flow variables were measured for the three recordings. The presence and degree of obstruction were determined using commonly recognized grading systems, i.e. the Abrams-Griffiths nomogram. the linear passive urethral resistance ratio (LPURR) and the urethral resistance algorithm (URA).
There were statistically significant differences in the detrusor pressure at maximum flow and detrusor opening pressure between the uninstrumented and instrumented studies (12 F and 17 F) but no difference in peak flow rates between the groups or in the Abrams-Griffiths number or URA value between studies. Using the LPURR, there was a tendency to a lower obstruction class after urethral instrumentation, ranking as 17 F > 12 F > no instrumentation.
The changes seen after urethral instrumentation represent no more than the biological intra-individual variation normally seen in pressure-flow studies and do not lead to a clinically significant change in obstruction class.
通过耻骨上膀胱内压力监测,确定尿道器械操作对下尿路症状(LUTS)男性患者压力-流率研究值及随后膀胱出口梗阻(BOO)分级的影响。
72例LUTS男性患者接受了耻骨上膀胱内压力监测的压力-流率研究。随后依次用12F导管和17F膀胱镜对尿道进行器械操作,每次操作后记录进一步的压力-流率研究。对三次记录测量标准压力-流率变量。使用公认的分级系统,即艾布拉姆斯-格里菲思列线图、线性被动尿道阻力比(LPURR)和尿道阻力算法(URA)确定梗阻的存在和程度。
未进行器械操作和进行器械操作(12F和17F)研究之间,最大尿流率时逼尿肌压力和逼尿肌开放压力存在统计学显著差异,但各组间峰值尿流率以及各研究间艾布拉姆斯-格里菲思数值或URA值无差异。使用LPURR,尿道器械操作后梗阻分级有降低趋势,顺序为17F>12F>未进行器械操作。
尿道器械操作后出现的变化仅代表压力-流率研究中通常所见的个体内生物学变异,不会导致梗阻分级出现临床上的显著变化。